4:00pm
to
5:00pm |
|
Virginia Tech Center for Drug Discovery Seminar Series
(Seminar/Conference)
Dr. Paul Joseph will present "Assays, tools, and techniques for compound screening, validation, and elucidation of mechanism."
Dr. Paul Joseph is a field application scientist from EMD Millipore, which is owned by the German pharmaceutical company Merck. EMD Millipore is the Bioscience division of Merck. They also own Upstate, Calbiochem, Chemicon, Linco, Novagen, Novabiochem, Millipore, etc. He will give a capabilities seminar, giving an overview of various assays, tools, techniques, etc. associated with compound screening and compound validation and elucidation of compound mechanism. He recently gave a similar seminar at NIH (National Center for Advancing Translational Sciences/Chemical Genomics).
More information...
|
